npj Genomic Medicine (Mar 2025)

The Utah NeoSeq Project: a collaborative multidisciplinary program to facilitate genomic diagnostics in the neonatal intensive care unit

  • Sabrina Malone Jenkins,
  • Rachel N. Palmquist,
  • Barry Moore,
  • Steven E. Boyden,
  • Thomas J. Nicholas,
  • Pinar Bayrak-Toydemir,
  • Rong Mao,
  • J. Andrew R. Farrell,
  • Carson H. Holt,
  • Shawn G. Rynearson,
  • Chelsea M. Solorzano,
  • Alistair Ward,
  • D. Hunter Best,
  • Najla Al-Sweel,
  • Dawn L. Bentley,
  • Luca Brunelli,
  • Clement Y. Chow,
  • Devin W. Close,
  • Michael J. Cormier,
  • Malia J. Deshotel,
  • Jacob Durtschi,
  • Erik J. Eide,
  • Luaiva Floyd,
  • Eric K. Fredrickson,
  • Makenzie L. Fulmer,
  • Edgar J. Hernandez,
  • Ashley L. Kapron,
  • Mary Anne Karren,
  • Robert G. Lewis,
  • Christine E. Miller,
  • L. Charles Murtaugh,
  • Kelsey E. Nicholson,
  • Katherine Noble,
  • Brendan D. O’Fallon,
  • John M. O’Shea,
  • David C. Pattison,
  • Brent S. Pedersen,
  • Brandy J. Petersen,
  • Bennet D. Peterson,
  • Lucilla Pizzo,
  • Hayley M. Reynolds,
  • Paul Rindler,
  • Carrie B. Torr,
  • Ting Wen,
  • H. Joseph Yost,
  • Jian Zhao,
  • Mark Yandell,
  • Gabor T. Marth,
  • Aaron R. Quinlan,
  • John C. Carey,
  • Brian J. Shayota,
  • Martin Tristani-Firouzi,
  • Joshua L. Bonkowsky

DOI
https://doi.org/10.1038/s41525-025-00483-7
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Rapid genomic diagnostics in the Neonatal Intensive Care Unit represents a paradigm shift in medicine with increasing evidence of the utility of early diagnosis, impacting management. The goal of the Utah NeoSeq Project was to implement and evaluate a multidisciplinary and longitudinal rapid sequencing program while transitioning to CLIA-certified sequencing. Enrollment of 65 infants resulted in 26 (40%) with a diagnostic variant(s) and 7 (11%) harboring a strong candidate. This includes re-analyses resulting in four additional diagnoses. Parental surveys indicated that 7% (4/59) of parents had a decisional conflict after consent, and 3% (2/59) experienced decisional regret after the results. Fifty-two provider surveys were conducted. Seventy-nine percent (41/52) of results and 86% (19/22) of diagnostic results were “very useful” or “useful” and associated with management changes. The NeoSeq Project demonstrates that a multidisciplinary collaborative approach to diagnosis is feasible. We have developed a generalizable, collaborative protocol that addresses the need for expedited genetic evaluation with emerging technologies.